Anzeige
Mehr »
Login
Freitag, 24.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 877757 | ISIN: FR0000051732 | Ticker-Symbol: AXI
Frankfurt
24.01.25
20:07 Uhr
0,002 Euro
0,000
-4,55 %
1-Jahres-Chart
ATOS SE Chart 1 Jahr
5-Tage-Chart
ATOS SE 5-Tage-Chart
RealtimeGeldBriefZeit
0,0020,00220:32
0,0020,00220.12.24
GlobeNewswire (Europe)
929 Leser
Artikel bewerten:
(2)

Atos International: Eviden ranked as a Market Leader in Analytics, AI, Data Platforms and Automation (AADA) in HFS Research Quadfecta Assessment for 2024

Finanznachrichten News


Press release

Eviden ranked as a Market Leader in Analytics, AI, Data Platforms and Automation (AADA) in HFS Research Quadfecta Assessment for 2024

Paris, France - December 12th, 2024 -Eviden, the Atos Groupbusiness leading in digital, cloud, big data and security, today announces that it has been ranked as a Market Leader in HFS Horizons: AADA Quadfecta Services for the Generative Enterprise, 2024 report.

This report assesses 27 service providers on how effectively they are helping their clients embrace the AADA quadfecta (Analytics, AI, Data Platforms and Automation) to drive innovation and realize value. This quadfecta encompasses key domains such as AI and GenAI, cloud-first data modernization, strategic talent development, and automation-driven business operations. This study evaluates the capabilities of providers across the AADA value chain based on a range of dimensions to understand the why, what, how, and so what of their service offerings.

In this report, Market Leaders (Horizon 3), such as Eviden, are well on their way to helping clients become Generative Enterprises by bringing together the right mix of tech, talent, IP, and delivery, leading to effective outcomes. Eviden is one of the few digital transformation providers that can deliver end-to-end solutions, from modernizing enterprise data architecture and leveraging optimal infrastructure-whether on cloud or edge-to incorporating robust security measures and building ethical, responsible systems. With its AI-enabled analytics and automation offerings, supported by a global team of 8,000 data and AI experts, Eviden ensures that business can extract meaningful insights from their data and drive automation to maximize ROI.

Ashish Chaturvedi,HFS Research Practice Leader said "Eviden's robust bundle of analytics, AI, data and automation offerings, delivered across multiple industries, can help enterprises become agile, frictionless, and autonomous. Through its Responsible AI Framework, Eviden helps customers design and build ethical, explainable, and secure AI solutions, using an end-to-end consulting approach that leverages a team of 8,000+ data and AI experts globally. Eviden's deep collaboration with partners such as Google Cloudand Databricks enhance its ability to deliver tailored solutions such as advanced data architectures and AI-powered business processes, resulting in clear and impressive business outcomes for clients."

Chetan Manjarekar, SVP & Global Head of Digital, Smart Platforms & Transformationat Eviden, Atos Group said "As we stand on the brink of the AI revolution, it's clear that AI and generative AI are not standalone solutions. To unlock their full potential, enterprises need partners with deep expertise across a broad range of technologies-including Data, Analytics, Automation, Cloud Computing, Security, and Responsible AI-alongside core competencies like model development, MLOps, and Data Science. This research takes a comprehensive view, evaluating not only technological capabilities but also our real-world experience of delivering tangible benefits to customers."

To find out more about Eviden's AADA solutions, go to Digital Transformation and Acceleration for Business Growth | Eviden

To download a full copy of the report, go to: https://www.hfsresearch.com/research/hfs-horizons-aada-quadfecta-services-for-the-generative-enterprise-2024/

***

About Eviden [1]

Evidenis a next-gen technology leader in data-driven, trusted and sustainable digital transformation with a strong portfolio of patented technologies. With worldwide leading positions in advanced computing, security, AI, cloud and digital platforms, it provides deep expertise for all industries in more than 47 countries. Bringing together 41,000 world-class talents, Eviden expands the possibilities of data and technology across the digital continuum, now and for generations to come. Eviden is an Atos Group company with an annual revenue of c. € 5 billion.

About Atos

Atos is a global leader in digital transformation with c. 82,000 employees and annual revenue of c. € 10 billion. European number one in cybersecurity, cloud and high-performance computing, the Group provides tailored end-to-end solutions for all industries in 69 countries. A pioneer in decarbonization services and products, Atos is committed to a secure and decarbonized digital for its clients. Atos is a SE (Societas Europaea) and listed on Euronext Paris.

The purpose of Atosis to help design the future of the information space. Its expertise and services support the development of knowledge, education and research in a multicultural approach and contribute to the development of scientific and technological excellence. Across the world, the Group enables its customers and employees, and members of societies at large to live, work and develop sustainably, in a safe and secure information space.

[1] Eviden business is operated through the following brands: AppCentrica, ATHEA, Cloudamize, Cloudreach, Cryptovision, DataSentics, Edifixio, Energy4U, Engage ESM, Evidian, Forensik, IDEAL GRP, In Fidem, Ipsotek, Maven Wave, Profit4SF, SEC Consult, Visual BI, Worldgrid, X-Perion. Eviden is a registered trademark.

Eviden is a registered trademark. © Eviden SAS, 2024.

Press contact

Zohra Dali - zohra.dali.external@eviden.com- +33 (0) 6 71 92 71 87

Attachment

  • Eviden ranked as a Market Leader by HSF Research (https://ml-eu.globenewswire.com/Resource/Download/14fb2cf7-cfaa-4904-a88a-870d53192c88)

© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.